Emmaus Life Sciences Statistics
Total Valuation
EMMA has a market cap or net worth of 989,916. The enterprise value is 32.50 million.
| Market Cap | 989,916 |
| Enterprise Value | 32.50M |
Important Dates
The next estimated earnings date is Wednesday, September 10, 2025.
| Earnings Date | Sep 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EMMA has 63.87 million shares outstanding. The number of shares has increased by 9.16% in one year.
| Current Share Class | 63.87M |
| Shares Outstanding | 63.87M |
| Shares Change (YoY) | +9.16% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 29.80% |
| Owned by Institutions (%) | n/a |
| Float | 39.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.07 |
| PB Ratio | -0.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.60 |
| EV / Sales | 2.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.16 |
Financial Position
The company has a current ratio of 0.08
| Current Ratio | 0.08 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -15.11 |
| Interest Coverage | -0.20 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -2.75% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 2.80% |
| Revenue Per Employee | 399,800 |
| Profits Per Employee | -96,743 |
| Employee Count | 35 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 0.73 |
Taxes
| Income Tax | -581,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +416.67% in the last 52 weeks. The beta is 8.12, so EMMA's price volatility has been higher than the market average.
| Beta (5Y) | 8.12 |
| 52-Week Price Change | +416.67% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 55.63 |
| Average Volume (20 Days) | 11,892 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EMMA had revenue of 13.99 million and -3.39 million in losses. Loss per share was -0.05.
| Revenue | 13.99M |
| Gross Profit | 12.92M |
| Operating Income | -1.09M |
| Pretax Income | -3.97M |
| Net Income | -3.39M |
| EBITDA | -1.07M |
| EBIT | -1.09M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 886,000 in cash and 32.39 million in debt, giving a net cash position of -31.51 million or -0.49 per share.
| Cash & Cash Equivalents | 886,000 |
| Total Debt | 32.39M |
| Net Cash | -31.51M |
| Net Cash Per Share | -0.49 |
| Equity (Book Value) | -55.70M |
| Book Value Per Share | -0.87 |
| Working Capital | -57.06M |
Cash Flow
In the last 12 months, operating cash flow was -2.14 million and capital expenditures -6,000, giving a free cash flow of -2.14 million.
| Operating Cash Flow | -2.14M |
| Capital Expenditures | -6,000 |
| Free Cash Flow | -2.14M |
| FCF Per Share | -0.03 |
Margins
Gross margin is 92.30%, with operating and profit margins of -7.76% and -24.20%.
| Gross Margin | 92.30% |
| Operating Margin | -7.76% |
| Pretax Margin | -28.35% |
| Profit Margin | -24.20% |
| EBITDA Margin | -7.63% |
| EBIT Margin | -7.76% |
| FCF Margin | n/a |
Dividends & Yields
EMMA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.16% |
| Shareholder Yield | n/a |
| Earnings Yield | -342.05% |
| FCF Yield | -216.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |